Donor Stem Cell Transplantation Associated With Survival Benefit For Patients With Leukemia
Thursday, June 18, 2009 - 23:28
in Health & Medicine
An analysis of previous studies indicates that allogeneic stem cell transplantation (SCT -- stem cells from a compatible donor) is associated with significant overall and relapse-free survival benefit among adult patients with intermediate- and poor-risk but not good-risk acute myeloid leukemia in first complete remission, compared with nonallogeneic SCT therapies.